Optimizing medication therapy in elderly patients: The impact of medication review using STOPP and START criteria version 2.

IF 1 4区医学 Q4 ONCOLOGY

Journal of Oncology Pharmacy Practice Pub Date : 2024-11-18 DOI:10.1177/10781552241296882

Silpa Murali, Aswin Damodaran, Namita Maria Jacob, Anjaly Venugopal, Joveena Johnson, Meenu Vijayan, K Pavithran, M Sonal Sekhar

{"title":"Optimizing medication therapy in elderly patients: The impact of medication review using STOPP and START criteria version 2.","authors":"Silpa Murali, Aswin Damodaran, Namita Maria Jacob, Anjaly Venugopal, Joveena Johnson, Meenu Vijayan, K Pavithran, M Sonal Sekhar","doi":"10.1177/10781552241296882","DOIUrl":null,"url":null,"abstract":"Background: Higher prevalence of inappropriate medication use among cancer patients increases risk of drug-related problems(DRP) like drug-drug interactions, ADR, and non-adherence. Potentially inappropriate medication (PIM) and Potential Prescription Omission (PPO) were identified using Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tool to Alert Doctors to the Right Treatment (START) criteria. Objectives: The study objective was to optimize prescriptions for the elderly by analyzing the impact of medication review. Methods: An observational study in which PIM and/or PPO were identified and the prescriptions were optimized by a physician. Results: Out of 150 patients, a total of 35 drugs were stopped and 12 drugs were started. Medication omissions were identified in 12 patients (8%). There were no DRPs associated with medication adjustments. Conclusion: Based on a pharmacist-led comprehensive medication review of the elderly, the STOPP and START criteria allow the optimization of prescriptions.","PeriodicalId":16637,"journal":{"name":"Journal of Oncology Pharmacy Practice","volume":" ","pages":"10781552241296882"},"PeriodicalIF":1.0000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology Pharmacy Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10781552241296882","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Higher prevalence of inappropriate medication use among cancer patients increases risk of drug-related problems(DRP) like drug-drug interactions, ADR, and non-adherence. Potentially inappropriate medication (PIM) and Potential Prescription Omission (PPO) were identified using Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tool to Alert Doctors to the Right Treatment (START) criteria. Objectives: The study objective was to optimize prescriptions for the elderly by analyzing the impact of medication review. Methods: An observational study in which PIM and/or PPO were identified and the prescriptions were optimized by a physician. Results: Out of 150 patients, a total of 35 drugs were stopped and 12 drugs were started. Medication omissions were identified in 12 patients (8%). There were no DRPs associated with medication adjustments. Conclusion: Based on a pharmacist-led comprehensive medication review of the elderly, the STOPP and START criteria allow the optimization of prescriptions.

查看原文本刊更多论文

优化老年患者的药物治疗：使用 STOPP 和 START 标准 2 版进行药物审查的影响。

背景：癌症患者用药不当的发生率较高，这增加了药物相关问题（DRP）的风险，如药物相互作用、药物不良反应和不依从性。我们使用老年人处方筛查工具（STOPP）和提醒医生正确治疗的筛查工具（START）标准来确定潜在的用药不当（PIM）和潜在的处方遗漏（PPO）。研究目标研究目的是通过分析药物审查的影响来优化老年人的处方。方法：一项观察性研究，其中确定了 PIM 和/或 PPO，并由一名医生对处方进行优化。结果在 150 名患者中，共有 35 种药物被停用，12 种药物被启用。发现有 12 名患者（8%）漏服药物。没有与药物调整相关的 DRP。结论基于药剂师主导的老年人综合用药检查，STOPP 和 START 标准可优化处方。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Oncology Pharmacy Practice Medicine-Oncology

CiteScore

2.70

自引率

7.70%

发文量

276

期刊介绍： Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...